Cargando…
Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial
BACKGROUND: To compare the effects of resistance training versus passive physical therapy on bone turnover markers (BTM) in the metastatic bone during radiation therapy (RT) in patients with spinal bone metastases. Secondly, to evaluate an association of BTM to local response, skeletal-related event...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794897/ https://www.ncbi.nlm.nih.gov/pubmed/26983672 http://dx.doi.org/10.1186/s12885-016-2278-1 |
_version_ | 1782421545076916224 |
---|---|
author | Rief, Harald Omlor, Georg Akbar, Michael Bruckner, Thomas Rieken, Stefan Förster, Robert Schlampp, Ingmar Welzel, Thomas Bostel, Tilman Roth, Heinz Jürgen Debus, Jürgen |
author_facet | Rief, Harald Omlor, Georg Akbar, Michael Bruckner, Thomas Rieken, Stefan Förster, Robert Schlampp, Ingmar Welzel, Thomas Bostel, Tilman Roth, Heinz Jürgen Debus, Jürgen |
author_sort | Rief, Harald |
collection | PubMed |
description | BACKGROUND: To compare the effects of resistance training versus passive physical therapy on bone turnover markers (BTM) in the metastatic bone during radiation therapy (RT) in patients with spinal bone metastases. Secondly, to evaluate an association of BTM to local response, skeletal-related events (SRE), and number of metastases. METHODS: In this randomized trial, 60 patients were allocated from September 2011 to March 2013 into one of the two arms: resistance training (Arm A) or passive physical therapy (Arm B) with thirty patients in each arm during RT. Biochemical markers such as pyridinoline (PYD), desoxy-pyridinoline (DPD), bone alkaline phosphatase (BAP), total amino-terminal propeptide of type I collagen (PINP), beta-isomer of carboxy-terminal telopeptide of type I collagen (CTX-I), and cross-linked N-telopeptide of type I collagen (NTX) were analyzed at baseline, and three months after RT. RESULTS: Mean change values of PYD and CTX-I were significantly lower at 3 months after RT (p = 0.035 and p = 0.043) in Arm A. Importantly, all markers decreased in both arms, except of PYD and CTX-I in arm B, although significance was not reached for some biomarkers. In arm A, the local response was significantly higher (p = 0.003) and PINP could be identified as a predictor for survivors (OR 0.968, 95%CI 0.938–0.999, p = 0.043). BAP (OR 0.974, 95%CI 0.950–0.998, p = 0.034) and PINP (OR 1.025, 95%CI 1.001–1.049, p = 0.044) were related with an avoidance of SRE. CONCLUSIONS: In this group of patients with spinal bone metastases, we were able to show that patients with guided resistance training of the paravertebral muscles can influence BTM. PYD and CTX-I decreased significantly in arm A. PINP can be considered as a complementary tool for prediction of local response, and PINP as well as BAP for avoidance of SRE. TRIAL REGISTRATION: Clinical trial identifier NCT 01409720. August 2, 2011. |
format | Online Article Text |
id | pubmed-4794897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47948972016-03-17 Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial Rief, Harald Omlor, Georg Akbar, Michael Bruckner, Thomas Rieken, Stefan Förster, Robert Schlampp, Ingmar Welzel, Thomas Bostel, Tilman Roth, Heinz Jürgen Debus, Jürgen BMC Cancer Research Article BACKGROUND: To compare the effects of resistance training versus passive physical therapy on bone turnover markers (BTM) in the metastatic bone during radiation therapy (RT) in patients with spinal bone metastases. Secondly, to evaluate an association of BTM to local response, skeletal-related events (SRE), and number of metastases. METHODS: In this randomized trial, 60 patients were allocated from September 2011 to March 2013 into one of the two arms: resistance training (Arm A) or passive physical therapy (Arm B) with thirty patients in each arm during RT. Biochemical markers such as pyridinoline (PYD), desoxy-pyridinoline (DPD), bone alkaline phosphatase (BAP), total amino-terminal propeptide of type I collagen (PINP), beta-isomer of carboxy-terminal telopeptide of type I collagen (CTX-I), and cross-linked N-telopeptide of type I collagen (NTX) were analyzed at baseline, and three months after RT. RESULTS: Mean change values of PYD and CTX-I were significantly lower at 3 months after RT (p = 0.035 and p = 0.043) in Arm A. Importantly, all markers decreased in both arms, except of PYD and CTX-I in arm B, although significance was not reached for some biomarkers. In arm A, the local response was significantly higher (p = 0.003) and PINP could be identified as a predictor for survivors (OR 0.968, 95%CI 0.938–0.999, p = 0.043). BAP (OR 0.974, 95%CI 0.950–0.998, p = 0.034) and PINP (OR 1.025, 95%CI 1.001–1.049, p = 0.044) were related with an avoidance of SRE. CONCLUSIONS: In this group of patients with spinal bone metastases, we were able to show that patients with guided resistance training of the paravertebral muscles can influence BTM. PYD and CTX-I decreased significantly in arm A. PINP can be considered as a complementary tool for prediction of local response, and PINP as well as BAP for avoidance of SRE. TRIAL REGISTRATION: Clinical trial identifier NCT 01409720. August 2, 2011. BioMed Central 2016-03-17 /pmc/articles/PMC4794897/ /pubmed/26983672 http://dx.doi.org/10.1186/s12885-016-2278-1 Text en © Rief et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Rief, Harald Omlor, Georg Akbar, Michael Bruckner, Thomas Rieken, Stefan Förster, Robert Schlampp, Ingmar Welzel, Thomas Bostel, Tilman Roth, Heinz Jürgen Debus, Jürgen Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial |
title | Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial |
title_full | Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial |
title_fullStr | Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial |
title_full_unstemmed | Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial |
title_short | Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial |
title_sort | biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794897/ https://www.ncbi.nlm.nih.gov/pubmed/26983672 http://dx.doi.org/10.1186/s12885-016-2278-1 |
work_keys_str_mv | AT riefharald biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial AT omlorgeorg biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial AT akbarmichael biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial AT brucknerthomas biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial AT riekenstefan biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial AT forsterrobert biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial AT schlamppingmar biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial AT welzelthomas biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial AT bosteltilman biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial AT rothheinzjurgen biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial AT debusjurgen biochemicalmarkersofboneturnoverinpatientswithspinalmetastasesafterresistancetrainingunderradiotherapyarandomizedtrial |